PD-L1 antibody
Quick Overview for PD-L1 antibody (ABIN6961455)
Target
See all PD-L1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purification
- This monoclonal antibody preparation was purified from tissue culture supernatant via affinity chromatography. For In Vivo Ready™ (IVR) products, each preparation is also evaluated for endotoxin levels using the LAL assay. It is recommended to store the product undiluted at 4°C. Do not freeze.
-
Endotoxin Level
- Low endotoxin: < 0.01 EU/ug
-
Isotype
- IgG2b kappa
-
-
-
-
Application Notes
- This purified format is guaranteed to be >90 % pure as determined by SDS-PAGE analysis.
-
Comment
-
2 mg/mL
-
Restrictions
- For Research Use only
-
-
-
Buffer
- 10 mM NaH2PO4, 150 mM NaCl, pH 7.2
-
Preservative
- Azide free
-
Storage
- 4 °C
-
Storage Comment
- 2-8°C
-
Expiry Date
- 12 months
-
-
- PD-L1 (CD274 (PD-L1))
-
Alternative Name
- CD274 (PD-L1, B7-H1)
-
Background
- The 10F.9G2 antibody is specific for mouse CD274, more commonly known as PD-L1 or B7-H1, which acts as a ligand for the T cell co-regulatory receptor PD-1 (CD279). This interaction modulates T cell antigen receptor (TCR) signaling and therefore T cell activation. PD-L1 binding to PD-1 expressed on CD4- CD8- thymocytes participates in the processes of clonal selection, elimination of autoreac- tive lymphocytes, and development of tolerance. PD-L1 may also bind PD-1 following the receptor's inducible expression on activated, mature T cells, where it has been proposed to limit T cell activation. PD-L1 is one of a group of ""B7"" ligands whose interactions with the CD28 receptor family, also including CTLA-4 (CD152), provide a balance of co-stimulatory /co-inhibitory signaling important in T cell acti- vation, tolerance, and autoimmunity.The 10F.9G2 antibody may be used as a marker for PD-L1 expression on T and B cells, NK cells and on dendritic cells. It is also widely used for analysis of receptor-ligand interaction and function(s) in vitro and in vivo.
-
Gene ID
- 60533
-
Pathways
- Cancer Immune Checkpoints
Target
-